Dr. Mohamedtaki A. Tejani
Claim this profileAdventHealth Orlando
Studies Adenocarcinoma
Studies Colorectal Cancer
17 reported clinical trials
35 drugs studied
Area of expertise
1Adenocarcinoma
BRCA1 positive
BRCA2 positive
PALB2 positive
2Colorectal Cancer
Stage III
Stage IV
dMMR positive
Affiliated Hospitals
Clinical Trials Mohamedtaki A. Tejani is currently running
Regorafenib + Pembrolizumab
for Colorectal Cancer
This is a trial of Regorafenib in combination with pembrolizumab for patients with MSI-H colorectal cancer consisting of lead-in phase examining preliminary efficacy and safety, followed by a randomized phase to further examine efficacy.
Recruiting1 award Phase 2
Olaparib
for Pancreatic Cancer
This phase II trial investigates how well the addition of olaparib following completion of surgery and chemotherapy works in treating patients with pancreatic cancer that has been surgically removed (resected) and has a pathogenic mutation in BRCA1, BRCA2, or PALB2. Olaparib is an inhibitor of PARP, an enzyme that helps repair deoxyribonucleic acid (DNA) when it becomes damaged. Blocking PARP may help keep tumor cells from repairing their damaged DNA, causing them to die. PARP inhibitors are a type of targeted therapy.
Recruiting0 awards Phase 232 criteria
More about Mohamedtaki A. Tejani
Clinical Trial Related2 years of experience running clinical trials · Led 17 trials as a Principal Investigator · 8 Active Clinical TrialsTreatments Mohamedtaki A. Tejani has experience with
- Nivolumab
- Oxaliplatin
- Paclitaxel
- Fluorouracil
- Carboplatin
- Ipilimumab
Breakdown of trials Mohamedtaki A. Tejani has run
Adenocarcinoma
Colorectal Cancer
Pancreatic Cancer
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mohamedtaki A. Tejani specialize in?
Mohamedtaki A. Tejani focuses on Adenocarcinoma and Colorectal Cancer. In particular, much of their work with Adenocarcinoma has involved BRCA1 positive patients, or patients who are BRCA2 positive.
Is Mohamedtaki A. Tejani currently recruiting for clinical trials?
Yes, Mohamedtaki A. Tejani is currently recruiting for 8 clinical trials in Orlando Florida. If you're interested in participating, you should apply.
Are there any treatments that Mohamedtaki A. Tejani has studied deeply?
Yes, Mohamedtaki A. Tejani has studied treatments such as Nivolumab, Oxaliplatin, Paclitaxel.
What is the best way to schedule an appointment with Mohamedtaki A. Tejani?
Apply for one of the trials that Mohamedtaki A. Tejani is conducting.
What is the office address of Mohamedtaki A. Tejani?
The office of Mohamedtaki A. Tejani is located at: AdventHealth Orlando, Orlando, Florida 32803 United States. This is the address for their practice at the AdventHealth Orlando.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.